Though lockdown regulations have been relaxed in most countries, individuals are still reluctant to visit doctors in person, owing to the fear of acquiring coronavirus (COVID-19). Hence, companies in the warts therapeutics market are tapping opportunities in telemedicine, since individuals prefer remote healthcare services amidst the COVID-19 era. As such, the demand for telehealth technology is anticipated to rise dramatically in the upcoming months and years. Telemedicine apps are helping to expedite the process of quality medical care in the sphere of warts therapeutics.
The critical need for social distancing between clinicians and patients has catalyzed the demand for telemedicine services in the domain of warts therapeutics. Due to high prevalence of active COVID-19 cases in the U.S., telemedicine services are expected to register a staggering market growth during the pandemic. This is expected to drive the warts therapeutics market during the forecast period.
The microwave technology is an innovative treatment option, which is transforming the market for warts therapeutics. For instance, Scotland-based medical equipment supplier Emblation Ltd., has gained proficiency in microwave technology and named it Swift, which helps to stimulate the body’s own immune system to clear the HPV (Human Papillomavirus). Thus, podiatrists and dermatologists in the warts therapeutics market are benefitting from the introduction of microwave technology devices that are similar to the functionality of mobile phones.
Warts patients in the U.K. have been long-standing sufferers of the HPV. Moreover, limited options for treatment have influenced med-tech companies to gain efficacy in the microwave technology. Since the Scottish Government banned the use of liquid nitrogen in clinics, med-tech companies have gained the opportunity to innovate in the microwave technology. Success stories of patients are fueling the demand for non-invasive microwave technology devices.
There is a growing demand for wart treatment that offers no scarring post-treatment and provides lifetime of immunity against the HPV. Hence, companies in the warts therapeutics market are increasing their focus in cryotherapy, tissue keratolysis, and immunotherapy to increase patient outcomes. As such, tissue keratolysis involves the use of salicylic acid and is popular in over-the-counter (OTC) options for warts therapeutics. This is evident since salicylic acid, being a chemical destruction treatment option, is expected to register exponential revenue growth in the warts therapeutics market during the assessment period.
Evidence-based data shows that high efficacy of salicylic acid is grabbing the attention of both clinicians and patients. Salicylic acid’s cost efficiency and less painful attributes are being highly preferred by patients. On the other hand, topical retinoids are also emerging as anti-inflammatory agents that inhibit cell proliferation.
Clinical evidence of topical zinc oxide ointment holds promising potentials in warts therapeutics. As such, zinc is associated with immunotherapy, implying that the element regulates the body’s immune system to manage common warts. This explains why the revenue of immunomodulation treatment is projected for aggressive growth in the warts therapeutics market. As such, the global warts therapeutics market is estimated to reach ~US$ 2.4 Bn by the end of 2030.
Ready availability, low cost attributes, and low chance of complications associated with topical zinc oxide ointments are generating incremental opportunities for pharmaceutical companies. Clinicians are recommending zinc oxide ointments for the management of cutaneous viral warts. Similarly, Topical 5-fluorouracil (5-FU) is also emerging as an effective solution for warts, since 5-FU inhibits cellular proliferation. Hence, healthcare professionals are recommending 5-FU application under tape occlusion to derive better results in patients.
The trend of telemedicine is bringing about a significant change in the warts therapeutics market. For instance, in December 2019, GenieMD— a California-based virtual care delivery company, has introduced its telemedicine app called iVisit that helps to connect genital warts patients with the best physicians through a virtual visit. Such innovations are bolstering growth for the warts therapeutics market. Thus, telemedicine is helping to expedite the process for acquiring quality medical care, which is currently the need of the hour for patients suffering from genital warts.
Companies in the market of warts therapeutics are increasing their R&D muscle in developing improved formulations of vaccines for patients who have not been previously vaccinated against HPV. On the other hand, manufacturers are increasing their production capabilities to develop prescription creams and gels that help to effectively treat genital warts.
Cryotherapy serves as the gold standard for the treatment of warts. As such, cryotherapy, a part of physical destruction treatment, is expected to lead the warts therapeutics market in terms of treatment types. However, possible risks of scarring and chances of infection due to cryotherapy pose a major concern for warts patients. This explains why the warts therapeutics market is slated to register a modest CAGR of ~3% during the forecast period. Hence, pharmaceutical companies are suggesting combination therapy involving salicylic acid to reduce incidence of adverse events in patients.
On the other hand, cantharidin is acquiring popularity as an ancient Chinese medicine that aids in warts therapeutics. However, cantharidin is not FDA (Food and Drug Association)-approved, which is why patients are ordering the medicine from distributors where it is commonly acceptable to use cantharidin.
Analysts’ Viewpoint
The telehealth sector is projected to experience exponential growth amidst the COVID-19 pandemic, as individuals wants to know about remote medical care services for warts management. With continued growth of telemedicine, companies in the warts therapeutics market are increasing the availability of topical ointments and bleomycin, owing to their antibacterial and antitumor properties.
The topical zinc oxide ointment improves patient outcomes. However, zinc might have different penetration profiles and deliver variable amounts of elemental zinc in different patients. Hence, companies should educate patients to seek consultation from clinicians about combination therapy of zinc oxide ointment with salicylic acid to prevent any adverse events in patients.
Warts therapeutics market to reach valuation of ~US$ 2.4 Bn by 2030
Warts therapeutics market is anticipated to expand at a CAGR of ~3% from 2020 to 2030
Warts therapeutics market is driven by an increase in prevalence of warts & HPV infections
North America accounted for major share of the global warts therapeutics market
Key players in the global warts therapeutics market include GlaxoSmithKline plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd, Phio Pharmaceuticals Corp., Verrica Pharmaceuticals
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Warts Therapeutics Market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
Chapter 5. Key Insights
5.1. Pipeline Analysis – Warts Therapeutics Market
5.2. Global Warts Therapeutics Market – COVID-19 Impact Analysis
5.3. Global Warts Therapeutics Market – Regulatory Scenario
Chapter 6. Global Warts Therapeutics Market Analysis and Forecast, by Warts Type
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Global Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
6.3.1. Common Warts
6.3.2. Genital Warts
6.3.3. Flat Warts
6.3.4. Others
6.4. Global Warts Therapeutics Market Attractiveness, by Warts Type
Chapter 7. Global Warts Therapeutics Market Analysis and Forecast, by Treatment Type
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Global Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030
7.3.1. Physical Destruction
7.3.1.1. Freezing (Cryotherapy)
7.3.1.1.1. Liquid Nitrogen
7.3.1.1.2. Nitrous Oxide
7.3.1.1.3. Dimethyl Ether and Propane
7.3.1.2. Surgical Removal
7.3.1.3. Laser Treatment
7.3.2. Chemical Destruction
7.3.2.1. Bleomycin
7.3.2.2. Cantharidin
7.3.2.3. Salicylic acid
7.3.2.4. Others
7.3.3. Immunomodulation
7.3.3.1. Interferons
7.3.3.2. Zinc
7.3.3.3. Retinoid
7.4. Global Warts Therapeutics Market Attractiveness, by Treatment Type
Chapter 8. Global Warts Therapeutics Market Analysis and Forecast, by End-user
8.1. Key Findings / Developments
8.2. Introduction & Definition
8.3. Global Warts Therapeutics Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals
8.3.2. Clinic
8.3.3. Others
8.4. Global Warts Therapeutics Market Attractiveness, by End-user
Chapter 9. Global Warts Therapeutics Market Analysis and Forecast, by Geography/Region
9.1. Geographical Representation
9.2. Global Warts Therapeutics Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Warts Therapeutics Market Attractiveness, by Region
Chapter 10. North America Warts Therapeutics Market Analysis and Forecast
10.1. North America Warts Therapeutics Market Value Forecast, by Country , 2018–2030
10.1.1. U.S.
10.1.2. Canada
10.2. North America Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
10.3. North America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030
10.4. North America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
10.5. North America Warts Therapeutics Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Warts
10.5.3. By Treatment Type
10.5.4. By End-user
Chapter 11. Europe Warts Therapeutics Market Analysis and Forecast
11.1. Europe Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
11.1.1. Germany
11.1.2. France
11.1.3. U.K.
11.1.4. Spain
11.1.5. Italy
11.1.6. Rest of Europe
11.2. Europe Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
11.3. Europe Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030
11.4. Europe Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
11.5. Europe Warts Therapeutics Market Attractiveness Analysis
11.5.1. By Country/Sub-region
11.5.2. By Warts Type
11.5.3. By Treatment Type
11.5.4. By End-user
Chapter 12. Asia Pacific Warts Therapeutics Market Analysis and Forecast
12.1. Asia Pacific Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
12.1.1. Japan
12.1.2. China
12.1.3. India
12.1.4. Australia & New Zealand
12.1.5. Rest of APAC
12.2. Asia Pacific Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
12.3. Asia Pacific Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
12.4. Asia Pacific Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
12.5. Asia Pacific Warts Therapeutics Market Attractiveness Analysis
12.5.1. By Country/Sub-region
12.5.2. By Warts Type
12.5.3. By Treatment Center
12.5.4. By End-user
Chapter 13. Latin America Warts Therapeutics Market Analysis and Forecast
13.1. Latin America Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
13.1.1. Brazil
13.1.2. Mexico
13.1.3. Rest of Latin America
13.2. Latin America Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
13.3. Latin America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
13.4. Latin America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
13.5. Latin America Warts Therapeutics Market Attractiveness Analysis
13.5.1. By Country/Sub-region
13.5.2. By Warts Type
13.5.3. By Treatment Center
13.5.4. By End-user
Chapter 14. Middle East & Africa Warts Therapeutics Market Analysis and Forecast
14.1. Middle East & Africa Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030
14.1.1. GCC Countries
14.1.2. South Africa
14.1.3. Rest of Middle East & Africa
14.2. Middle East & Africa Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030
14.3. Middle East & Africa Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030
14.4. Middle East & Africa Warts Therapeutics Market Value Forecast, by End-user, 2018-2030
14.5. Middle East & Africa Warts Therapeutics Market Attractiveness Analysis
14.5.1. By Country/Sub-region
14.5.2. By Warts Type
14.5.3. By Treatment Center
14.5.4. By End-user
Chapter 15. Competition Landscape
15.1. Competition Matrix
15.1.1. Prestige Consumer Healthcare, Inc.
15.1.2. Bausch Health Companies, Inc.
15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
15.2.1. Prestige Consumer Healthcare, Inc.
15.2.1.1. Company Details
15.2.1.2. Company Description
15.2.1.3. Business Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Financial Analysis
15.2.1.6. Strategic Overview
15.2.2. Bausch Health Companies, Inc.
15.2.2.1. Company Details
15.2.2.2. Company Description
15.2.2.3. Business Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Phio Pharmaceuticals Corp.
15.2.3.1. Company Details
15.2.3.2. Company Description
15.2.3.3. Business Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Verrica Pharmaceuticals
15.2.4.1. Company Details
15.2.4.2. Company Description
15.2.4.3. Business Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Teva Pharmaceuticals Industries Ltd.
15.2.5.1. Company Details
15.2.5.2. Company Description
15.2.5.3. Business Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Financial Analysis
15.2.5.6. Strategic Overview
15.2.6. Mylan N.V.
15.2.6.1. Company Details
15.2.6.2. Company Description
15.2.6.3. Business Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Financial Analysis
15.2.6.6. Strategic Overview
15.2.7. Scholl’s Wellness Co.
15.2.7.1. Company Details
15.2.7.2. Company Description
15.2.7.3. Business Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Financial Analysis
15.2.7.6. Strategic Overview
15.2.8. Taro Pharmaceuticals Industries Ltd.
15.2.8.1. Company Details
15.2.8.2. Company Description
15.2.8.3. Business Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Financial Analysis
15.2.8.6. Strategic Overview
15.2.9. Cipla Ltd.
15.2.9.1. Company Details
15.2.9.2. Company Description
15.2.9.3. Business Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. GlaxoSmithKline plc
15.2.10.1. Company Details
15.2.10.2. Company Description
15.2.10.3. Business Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
15.2.11. Novan, Inc.
15.2.11.1. Company Details
15.2.11.2. Company Description
15.2.11.3. Business Overview
15.2.11.4. SWOT Analysis
15.2.11.5. Strategic Overview
15.2.12. AIM ImmunoTech, Inc.
15.2.12.1. Company Details
15.2.12.2. Company Description
15.2.12.3. Business Overview
15.2.12.4. SWOT Analysis
15.2.12.5. Strategic Overview
15.2.13. Merck & Co., Inc.
15.2.13.1. Company Details
15.2.13.2. Company Description
15.2.13.3. Business Overview
15.2.13.4. SWOT Analysis
15.2.13.5. Strategic Overview
List of Tables
Table 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 02: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 03: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 04: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing Cryotherapy, 2018–2030
Table 05: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 06: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 07: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 10: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 11: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 12: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 13: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 14: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 15: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 16: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 19: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 20: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 21: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 22: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 23: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 24: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 25: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 27: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 28: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 29: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 30: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 31: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 32: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 33: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 34: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 35: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 36: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 37: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 38: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 39: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 40: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 41: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 42: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030
Table 43: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030
Table 44: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030
Table 45: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030
Table 46: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030
Table 47: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030
Table 48: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figure
Figure 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Warts Therapeutics Market Value Share, by Wart Type, 2019
Figure 03: Global Warts Therapeutics Market Value Share, by Treatment Type, 2019
Figure 04: Global Warts Therapeutics Market Value Share, by End-user, 2019
Figure 05: Global Warts Therapeutics Market Value Share, by Region, 2019
Figure 06: Global Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
Figure 07: Global Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030
Figure 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Common Warts, 2018–2030
Figure 09: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Genital Warts, 2018–2030
Figure 10: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Flat Warts, 2018–2030
Figure 11: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030
Figure 12: Global Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 13: Global Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 14: Global Warts Therapeutics Market Value Share Analysis, by Physical Destruction, 2019 and 2030
Figure 15: Global Warts Therapeutics Market Attractiveness Analysis, by Physical Destruction, 2020–2030
Figure 16: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Physical Destruction, 2018–2030
Figure 17: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chemical Destruction, 2018–2030
Figure 18: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Immunomodulation, 2018–2030
Figure 19: Global Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 20: Global Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 21: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2018–2030
Figure 22: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Clinics, 2018–2030
Figure 23: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030
Figure 24: Global Warts Therapeutics Market Value Share Analysis, by Region, 2019 and 2030
Figure 25: Global Warts Therapeutics Market Attractiveness Analysis, by Region, 2020–2030
Figure 26: North America Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 27: North America Warts Therapeutics Market Value Share Analysis, by Country, 2019 and 2030
Figure 28: North America Warts Therapeutics Market Attractiveness Analysis, by Country, 2020–2030
Figure 29: North America Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
Figure 30: North America Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030
Figure 31: North America Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 32: North America Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 33: North America Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 34: North America Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 35: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 36: Europe Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 37: Europe Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 38: Europe Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
Figure 39: Europe Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030
Figure 40: Europe Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 41: Europe Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 42: Europe Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 43: Europe Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 44: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 45: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 46: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 47: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
Figure 48: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030
Figure 49: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 50: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 51: Asia Pacific Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 52: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 53: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 54: Latin America Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 55: Latin America Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 56: Latin America Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
Figure 57: Latin America Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030
Figure 58: Latin America Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 59: Latin America Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 60: Latin America Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 61: Latin America Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 62: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030
Figure 63: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 64: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 65: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030
Figure 66: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030
Figure 67: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030
Figure 68: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030
Figure 69: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 70: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Warts Therapeutics Market
